Citius Pharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target
Buy Rating Reaffirmed for Citius Pharmaceuticals Amid Strong Clinical Trial Results and Growth Prospects
Analysts Are Bullish on Top Healthcare Stocks: Citius Pharmaceuticals (CTXR), Actinium Pharmaceuticals (ATNM)
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Citius Pharmaceuticals (CTXR)
Analysts Offer Insights on Healthcare Companies: Minerva Neurosciences (NERV), Citius Pharmaceuticals (CTXR) and Amylyx Pharmaceuticals Inc (AMLX)
Analysts Are Bullish on These Healthcare Stocks: Blueprint Medicines (BPMC), Citius Pharmaceuticals (CTXR)
HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target
Citius Pharma Analyst Ratings
Buy Rating for Citius Pharmaceuticals Backed by Resubmission of Lymphir BLA and Potential Orphan Drug Exclusivity
Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR), Arcus Biosciences (RCUS) and Masimo (MASI)
Strong Buy Rating for Citius Pharmaceuticals Amid Promising Mino-Lok Progress and Strategic Oncology Spinout
HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target
Citius Pharma Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Citius Pharmaceuticals (CTXR), Aprea Therapeutics (APRE)
HC Wainwright & Co. Maintains Buy on Citius Pharma, Lowers Price Target to $4
Citius Pharma Analyst Ratings
Citius Pharmaceuticals (CTXR) Gets a Buy From H.C. Wainwright
Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR) and Abcam (ABCM)
Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI), Tempest Therapeutics (TPST) and Citius Pharmaceuticals (CTXR)
No Data